|
US46561A
(en)
*
|
|
1865-02-28 |
|
Improvement in machinery for crushing quartz |
|
AT252264B
(de)
|
1965-03-17 |
1967-02-10 |
Etapharm Chem Pharm Lab Ges M |
Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
|
|
US3845770A
(en)
*
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
SE390255B
(sv)
*
|
1974-02-18 |
1976-12-13 |
N G Y Torphammar |
Upprullningsanordning foretredesvis for ett sekerhetsbelte i ett fordon
|
|
GB1478759A
(en)
*
|
1974-11-18 |
1977-07-06 |
Alza Corp |
Process for forming outlet passageways in pills using a laser
|
|
US3966749A
(en)
*
|
1975-02-10 |
1976-06-29 |
Interx Research Corporation |
Novel synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols, the pharmaceutically acceptable acid addition salts thereof and intermediate useful in the preparation thereof
|
|
US4014335A
(en)
*
|
1975-04-21 |
1977-03-29 |
Alza Corporation |
Ocular drug delivery device
|
|
US4144317A
(en)
*
|
1975-05-30 |
1979-03-13 |
Alza Corporation |
Device consisting of copolymer having acetoxy groups for delivering drugs
|
|
US4052505A
(en)
*
|
1975-05-30 |
1977-10-04 |
Alza Corporation |
Ocular therapeutic system manufactured from copolymer
|
|
US4057619A
(en)
|
1975-06-30 |
1977-11-08 |
Alza Corporation |
Ocular therapeutic system with selected membranes for administering ophthalmic drug
|
|
US4063064A
(en)
|
1976-02-23 |
1977-12-13 |
Coherent Radiation |
Apparatus for tracking moving workpiece by a laser beam
|
|
US4186184A
(en)
*
|
1977-12-27 |
1980-01-29 |
Alza Corporation |
Selective administration of drug with ocular therapeutic system
|
|
US4190642A
(en)
*
|
1978-04-17 |
1980-02-26 |
Alza Corporation |
Ocular therapeutic system for dispensing a medication formulation
|
|
US4200098A
(en)
*
|
1978-10-23 |
1980-04-29 |
Alza Corporation |
Osmotic system with distribution zone for dispensing beneficial agent
|
|
US4285987A
(en)
*
|
1978-10-23 |
1981-08-25 |
Alza Corporation |
Process for manufacturing device with dispersion zone
|
|
US4303637A
(en)
|
1980-04-04 |
1981-12-01 |
Alza Corporation |
Medication indicated for ocular hypertension
|
|
US4281654A
(en)
*
|
1980-04-07 |
1981-08-04 |
Alza Corporation |
Drug delivery system for controlled ocular therapy
|
|
US4396625A
(en)
*
|
1980-05-13 |
1983-08-02 |
Sumitomo Chemical Company, Limited |
Treatment of glaucoma or ocular hypertension and ophthalmic composition
|
|
US4425346A
(en)
*
|
1980-08-01 |
1984-01-10 |
Smith And Nephew Associated Companies Limited |
Pharmaceutical compositions
|
|
US4304765A
(en)
|
1980-10-14 |
1981-12-08 |
Alza Corporation |
Ocular insert housing steroid in two different therapeutic forms
|
|
US4327725A
(en)
*
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4383992A
(en)
|
1982-02-08 |
1983-05-17 |
Lipari John M |
Water-soluble steroid compounds
|
|
JPS58126435U
(ja)
*
|
1982-02-19 |
1983-08-27 |
オリンパス光学工業株式会社 |
Ｔｔｌオ−トストロボ用絞り制御回路
|
|
US4599353A
(en)
*
|
1982-05-03 |
1986-07-08 |
The Trustees Of Columbia University In The City Of New York |
Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
|
|
DE3220156C2
(de)
*
|
1982-05-28 |
1990-01-25 |
Heida Houston Tex. Thurlow |
Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel
|
|
US4649151A
(en)
*
|
1982-09-27 |
1987-03-10 |
Health Research, Inc. |
Drugs comprising porphyrins
|
|
IT1229075B
(it)
|
1985-04-05 |
1991-07-17 |
Fidia Farmaceutici |
Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
|
|
US5166331A
(en)
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
|
US4478818A
(en)
*
|
1982-12-27 |
1984-10-23 |
Alza Corporation |
Ocular preparation housing steroid in two different therapeutic forms
|
|
US4521210A
(en)
*
|
1982-12-27 |
1985-06-04 |
Wong Vernon G |
Eye implant for relieving glaucoma, and device and method for use therewith
|
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US4727064A
(en)
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
US4693885A
(en)
*
|
1984-07-18 |
1987-09-15 |
Nippon Petrochemicals Co., Ltd. |
Tetrapyrrole therapeutic agents
|
|
US4675338A
(en)
*
|
1984-07-18 |
1987-06-23 |
Nippon Petrochemicals Co., Ltd. |
Tetrapyrrole therapeutic agents
|
|
FR2577509B1
(fr)
|
1985-02-21 |
1987-05-07 |
Nirvana Espar Systems Sa |
Mat de bateau a voile
|
|
US4656186A
(en)
*
|
1985-04-30 |
1987-04-07 |
Nippon Petrochemicals Co., Ltd. |
Tetrapyrrole therapeutic agents
|
|
US6407079B1
(en)
*
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
|
US4668506A
(en)
*
|
1985-08-16 |
1987-05-26 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing and amino acid polymer
|
|
FR2594438B1
(fr)
*
|
1986-02-14 |
1990-01-26 |
Labaz Sanofi Nv |
Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
|
|
AU604236B2
(en)
|
1986-04-28 |
1990-12-13 |
Iolab, Inc. |
Intraocular dosage compositions and method of use
|
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
|
IL80298A
(en)
|
1986-10-14 |
1993-01-31 |
Res & Dev Co Ltd |
Eye drops
|
|
US4863457A
(en)
*
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
|
US5089509A
(en)
*
|
1988-09-15 |
1992-02-18 |
Allergan, Inc. |
Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
|
|
US4981871A
(en)
*
|
1987-05-15 |
1991-01-01 |
Abelson Mark B |
Treatment of ocular hypertension with class I calcium channel blocking agents
|
|
DE3734223A1
(de)
|
1987-10-09 |
1989-04-20 |
Boehringer Ingelheim Kg |
Implantierbares, biologisch abbaubares wirkstofffreigabesystem
|
|
US4853224A
(en)
*
|
1987-12-22 |
1989-08-01 |
Visionex |
Biodegradable ocular implants
|
|
US4997652A
(en)
*
|
1987-12-22 |
1991-03-05 |
Visionex |
Biodegradable ocular implants
|
|
US4920104A
(en)
|
1988-05-16 |
1990-04-24 |
Medchem Products, Inc. |
Sodium hyaluronate composition
|
|
US4865846A
(en)
*
|
1988-06-03 |
1989-09-12 |
Kaufman Herbert E |
Drug delivery system
|
|
US4968715A
(en)
|
1988-07-06 |
1990-11-06 |
Health Research, Inc. |
Use of purified hematoporphyrin trimers in photodynamic therapy
|
|
US5190966A
(en)
*
|
1988-07-06 |
1993-03-02 |
Health Research, Inc. |
Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
|
|
US5002962A
(en)
*
|
1988-07-20 |
1991-03-26 |
Health Research, Inc. |
Photosensitizing agents
|
|
US5198460A
(en)
*
|
1988-07-20 |
1993-03-30 |
Health Research Inc. |
Pyropheophorbides and their use in photodynamic therapy
|
|
US5093349A
(en)
*
|
1988-07-20 |
1992-03-03 |
Health Research Inc. |
Photosensitizing agents
|
|
DE68929435T2
(de)
|
1988-09-06 |
2003-07-17 |
Pharmacia Ab, Stockholm |
Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
|
|
US5702716A
(en)
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US4935498A
(en)
*
|
1989-03-06 |
1990-06-19 |
Board Of Regents, The University Of Texas System |
Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
|
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
|
US5173504A
(en)
|
1989-04-21 |
1992-12-22 |
Health Research, Inc. |
Bacteriochlorophyll-a derivatives useful in photodynamic therapy
|
|
US5171741A
(en)
|
1989-04-21 |
1992-12-15 |
Health Research, Inc. |
Bacteriochlorophyll-a derivatives useful in photodynamic therapy
|
|
US5019400A
(en)
*
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US6271216B1
(en)
|
1989-07-24 |
2001-08-07 |
Allergan |
Stable solution of hyaluronate in a balanced salt medium
|
|
US5077049A
(en)
|
1989-07-24 |
1991-12-31 |
Vipont Pharmaceutical, Inc. |
Biodegradable system for regenerating the periodontium
|
|
US5487897A
(en)
*
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
|
US5324519A
(en)
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US5034413A
(en)
*
|
1989-07-27 |
1991-07-23 |
Allergan, Inc. |
Intraocular pressure reducing 9,11-diacyl prostaglandins
|
|
US5268178A
(en)
|
1989-09-25 |
1993-12-07 |
The Board Of Regents, The University Of Texas System |
Biodegradable antibiotic implants and methods of their use in treating and preventing infections
|
|
US5503721A
(en)
*
|
1991-07-18 |
1996-04-02 |
Hri Research, Inc. |
Method for photoactivation
|
|
US5051578A
(en)
|
1989-11-15 |
1991-09-24 |
Slemon Charles S |
Self calibrating fiber optic sensor system with optimized throughput
|
|
US5164188A
(en)
|
1989-11-22 |
1992-11-17 |
Visionex, Inc. |
Biodegradable ocular implants
|
|
US5075115A
(en)
|
1990-04-02 |
1991-12-24 |
Fmc Corporation |
Process for polymerizing poly(lactic acid)
|
|
US5232844A
(en)
*
|
1990-05-15 |
1993-08-03 |
New York Blood Center |
Photodynamic inactivation of viruses in cell-containing compositions
|
|
US5256408A
(en)
|
1990-06-12 |
1993-10-26 |
Insite Vision Incorporated |
Aminosteroids for ophthalmic use
|
|
US5209926A
(en)
|
1990-06-12 |
1993-05-11 |
Insite Vision Incorporated |
Aminosteroids for ophthalmic use
|
|
US5124154A
(en)
|
1990-06-12 |
1992-06-23 |
Insite Vision Incorporated |
Aminosteroids for ophthalmic use
|
|
US5100431A
(en)
*
|
1990-09-27 |
1992-03-31 |
Allergan, Inc. |
Single stitch suture needle and method
|
|
KR0185215B1
(ko)
*
|
1990-11-30 |
1999-05-01 |
요시다 쇼오지 |
서방성 안구삽입용 약제
|
|
US5492936A
(en)
|
1990-11-30 |
1996-02-20 |
Allergan, Inc. |
Bimodal molecular weight hyaluronate formulations and methods for using same
|
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
DK0591392T3
(da)
*
|
1991-06-21 |
1996-09-30 |
Genetics Inst |
Farmaceutiske formuleringer af osteogene proteiner
|
|
US5356629A
(en)
*
|
1991-07-12 |
1994-10-18 |
United States Surgical Corporation |
Composition for effecting bone repair
|
|
US5169638A
(en)
|
1991-10-23 |
1992-12-08 |
E. R. Squibb & Sons, Inc. |
Buoyant controlled release powder formulation
|
|
US5543154A
(en)
*
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
|
US5656297A
(en)
*
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
|
IT1263116B
(it)
|
1992-04-09 |
1996-07-30 |
Rotta Research Lab |
Derivati basici dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso farmaceutico
|
|
US5655832A
(en)
*
|
1992-04-16 |
1997-08-12 |
Tir Technologies, Inc. |
Multiple wavelength light processor
|
|
US5244914A
(en)
*
|
1992-04-27 |
1993-09-14 |
American Cyanamid Company |
Stable porfimer sodium compositions and methods for their manufacture
|
|
US5178635A
(en)
*
|
1992-05-04 |
1993-01-12 |
Allergan, Inc. |
Method for determining amount of medication in an implantable device
|
|
US6217869B1
(en)
*
|
1992-06-09 |
2001-04-17 |
Neorx Corporation |
Pretargeting methods and compounds
|
|
US5324718A
(en)
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
|
US5972991A
(en)
*
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5688819A
(en)
|
1992-09-21 |
1997-11-18 |
Allergan |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
|
US5922773A
(en)
*
|
1992-12-04 |
1999-07-13 |
The Children's Medical Center Corp. |
Glaucoma treatment
|
|
US5494901A
(en)
*
|
1993-01-05 |
1996-02-27 |
Javitt; Jonathan C. |
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
|
|
US5707643A
(en)
*
|
1993-02-26 |
1998-01-13 |
Santen Pharmaceutical Co., Ltd. |
Biodegradable scleral plug
|
|
WO1995003807A1
(en)
*
|
1993-07-27 |
1995-02-09 |
The University Of Sydney |
Treatment of age-related macular degeneration
|
|
US5504074A
(en)
*
|
1993-08-06 |
1996-04-02 |
Children's Medical Center Corporation |
Estrogenic compounds as anti-angiogenic agents
|
|
US5385887A
(en)
*
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
|
US5540930A
(en)
*
|
1993-10-25 |
1996-07-30 |
Pharmos Corporation |
Suspension of loteprednol etabonate for ear, eye, or nose treatment
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
DE4408498C2
(de)
|
1993-11-16 |
1997-06-12 |
Christian Eichler |
Umfülleinrichtung für die Medizin und die Pharmazie
|
|
US6051576A
(en)
*
|
1994-01-28 |
2000-04-18 |
University Of Kentucky Research Foundation |
Means to achieve sustained release of synergistic drugs by conjugation
|
|
DE4403326C1
(de)
*
|
1994-02-03 |
1995-06-22 |
Hans Reinhard Prof Dr Koch |
Intraokulare Linsenanordnung zur Astigmatismuskorrektur
|
|
US5516522A
(en)
*
|
1994-03-14 |
1996-05-14 |
Board Of Supervisors Of Louisiana State University |
Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
|
|
US5798349A
(en)
*
|
1994-03-14 |
1998-08-25 |
The General Hospital Corporation |
Use of green porphyrins to treat neovasculature in the eye
|
|
EP1125577B1
(en)
|
1994-04-08 |
2006-02-15 |
QLT USA, Inc. |
Liquid drug delivery compositions
|
|
ATE241394T1
(de)
*
|
1994-04-08 |
2003-06-15 |
Atrix Lab Inc |
Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung
|
|
US5466233A
(en)
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
US6270492B1
(en)
*
|
1994-09-09 |
2001-08-07 |
Cardiofocus, Inc. |
Phototherapeutic apparatus with diffusive tip assembly
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
US5565188A
(en)
|
1995-02-24 |
1996-10-15 |
Nanosystems L.L.C. |
Polyalkylene block copolymers as surface modifiers for nanoparticles
|
|
US6369116B1
(en)
*
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US5906920A
(en)
*
|
1995-08-29 |
1999-05-25 |
The Salk Institute For Biological Studies |
Methods for the detection of ligands for retinoid X receptors
|
|
US5776699A
(en)
*
|
1995-09-01 |
1998-07-07 |
Allergan, Inc. |
Method of identifying negative hormone and/or antagonist activities
|
|
US5958954A
(en)
*
|
1995-09-01 |
1999-09-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
|
US5877207A
(en)
*
|
1996-03-11 |
1999-03-02 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
|
US6066675A
(en)
*
|
1996-09-13 |
2000-05-23 |
The Regents Of The University Of California |
Method for treatment of retinal diseases
|
|
US5913884A
(en)
*
|
1996-09-19 |
1999-06-22 |
The General Hospital Corporation |
Inhibition of fibrosis by photodynamic therapy
|
|
WO1998024483A2
(en)
*
|
1996-12-03 |
1998-06-11 |
Osteobiologics, Inc. |
Biodegradable polymeric film
|
|
US6270749B1
(en)
*
|
1996-12-11 |
2001-08-07 |
Pharmacyclics, Inc. |
Use of Texaphyrin in ocular diagnosis and therapy
|
|
US6274614B1
(en)
*
|
1997-02-11 |
2001-08-14 |
Qlt Inc. |
Methods, compositions and articles for reducing or preventing the effects of inflammation
|
|
US5919970A
(en)
*
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
|
IL133105A
(en)
*
|
1997-06-04 |
2004-09-27 |
Debio Rech Pharma Sa |
Implants for controlled release of pharmaceutically active principles and method for making same
|
|
US6380261B1
(en)
*
|
1997-06-30 |
2002-04-30 |
Allergan Sales, Inc. |
Calcium blockers to treat proliferative vitreoretinopathy
|
|
EP1003569B1
(en)
*
|
1997-08-11 |
2004-10-20 |
Allergan, Inc. |
Sterile bioerodible implant device containing retinoid with improved biocompatability and method of manufacture
|
|
US6306426B1
(en)
*
|
1997-08-11 |
2001-10-23 |
Allergan Sales, Inc. |
Implant device with a retinoid for improved biocompatibility
|
|
US6271220B1
(en)
*
|
1998-03-11 |
2001-08-07 |
Allergan Sales, Inc. |
Anti-angiogenic agents
|
|
AU761205B2
(en)
*
|
1998-03-30 |
2003-05-29 |
Skyepharma Canada Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
|
EP1100366B1
(en)
|
1998-07-09 |
2009-04-15 |
Curelight Medical Ltd |
Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
|
|
CA2336703A1
(en)
|
1998-07-10 |
2000-01-20 |
The University Of Sydney |
Prophylactic treatments of neovascularisation in macular degeneration
|
|
US6261583B1
(en)
|
1998-07-28 |
2001-07-17 |
Atrix Laboratories, Inc. |
Moldable solid delivery system
|
|
US20020198174A1
(en)
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
|
WO2000012137A1
(en)
|
1998-09-02 |
2000-03-09 |
Allergan Sales, Inc. |
Preserved cyclodextrin-containing compositions
|
|
US20040152664A1
(en)
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
US6143314A
(en)
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
|
DE69924749T2
(de)
|
1998-11-20 |
2006-04-27 |
The University Of Connecticut, Farmington |
Generisch integrierte implantierbare Potentiostatfernmeßanordnung für elektrochemische Fühler
|
|
DE10008880A1
(de)
|
1999-02-19 |
2000-08-24 |
Bioserv Ag |
Bioabbaubare Komposite zur Herstellung von Mikrokapseln
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6482854B1
(en)
|
1999-03-25 |
2002-11-19 |
Massachusetts Eye And Ear Infirmary |
Glaucoma treatment
|
|
US6290713B1
(en)
*
|
1999-08-24 |
2001-09-18 |
Thomas A. Russell |
Flexible illuminators for phototherapy
|
|
US6317616B1
(en)
|
1999-09-15 |
2001-11-13 |
Neil David Glossop |
Method and system to facilitate image guided surgery
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US6319273B1
(en)
|
1999-12-16 |
2001-11-20 |
Light Sciences Corporation |
Illuminating device for treating eye disease
|
|
AUPQ496500A0
(en)
|
2000-01-06 |
2000-02-03 |
University Of Sydney, The |
Kit
|
|
US6395294B1
(en)
*
|
2000-01-13 |
2002-05-28 |
Gholam A. Peyman |
Method of visualization of the vitreous during vitrectomy
|
|
CA2398901C
(en)
|
2000-02-10 |
2010-11-16 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
US6375972B1
(en)
*
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6726918B1
(en)
*
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
PE20020146A1
(es)
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
ATE547080T1
(de)
*
|
2000-08-30 |
2012-03-15 |
Univ Johns Hopkins |
Vorrichtungen zur intraokularen arzneimittelabgabe
|
|
US6357568B1
(en)
*
|
2000-09-27 |
2002-03-19 |
Shou Mao Chen |
Structure for protecting a luggage shell
|
|
WO2002058730A2
(en)
|
2000-11-01 |
2002-08-01 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
EP1337237B1
(en)
|
2000-11-15 |
2009-03-11 |
Mohan A. Chandavarkar |
Pharmaceutical preparations comprising corticosteroids and antiinfective agents
|
|
US6699493B2
(en)
*
|
2000-11-29 |
2004-03-02 |
Oculex Pharmaceuticals, Inc. |
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
|
US6595945B2
(en)
*
|
2001-01-09 |
2003-07-22 |
J. David Brown |
Glaucoma treatment device and method
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
TWI298257B
(en)
|
2001-05-31 |
2008-07-01 |
Allergan Inc |
Hypotensive lipid and timolol compositions and methods of using same
|
|
AR034371A1
(es)
|
2001-06-08 |
2004-02-18 |
Novartis Ag |
Composiciones farmaceuticas
|
|
US6713268B2
(en)
|
2001-06-26 |
2004-03-30 |
Allergan, Inc. |
Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
|
|
DE60233414D1
(de)
*
|
2001-07-09 |
2009-10-01 |
Combinatorx Inc |
Kombinationen für die behandlung entzündlicher erkrankungen
|
|
US20030225152A1
(en)
|
2001-09-27 |
2003-12-04 |
Andrews Steven W. |
3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
|
|
HRP20040406A2
(en)
|
2001-11-09 |
2005-02-28 |
Eyetech Pharmaceuticals |
Methods for treating ocular neovascular diseases
|
|
US6960346B2
(en)
|
2002-05-09 |
2005-11-01 |
University Of Tennessee Research Foundation |
Vehicles for delivery of biologically active substances
|
|
CN1684663A
(zh)
*
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
|
US6899717B2
(en)
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
US7368126B2
(en)
*
|
2002-11-06 |
2008-05-06 |
Guohua Chen |
Controlled release depot formulations
|
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
|
WO2004069280A1
(en)
|
2003-02-06 |
2004-08-19 |
Cipla Ltd |
Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
|
|
US20070148192A1
(en)
|
2003-02-21 |
2007-06-28 |
Laddha Ritu N |
Stable ophthalmic composition
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US20060141049A1
(en)
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
|
US20050107727A1
(en)
*
|
2003-11-14 |
2005-05-19 |
Christian Hunt |
Cervical traction device
|
|
EP1706095B1
(en)
|
2004-01-20 |
2008-12-24 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
|
US20050244466A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US20050244471A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US20050244462A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
|
US20050244461A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US20050244465A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US20050244458A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20050244478A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
AU2005271700B2
(en)
|
2004-07-12 |
2010-11-11 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
|
WO2006043965A1
(en)
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20070298073A1
(en)
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US7379361B2
(en)
*
|
2006-07-24 |
2008-05-27 |
Kingston Technology Corp. |
Fully-buffered memory-module with redundant memory buffer in serializing advanced-memory buffer (AMB) for repairing DRAM
|